XXXX : risk factors and associated comorbidities; findings from the EpiLUTS study.

@entity1 @entity308 @entity1069 @entity101 @entity6 @entity625 @entity1494 @entity565 @entity263 @entity29 @entity148 @entity299 @entity2183
OBJECTIVE: To evaluate the risk factors and comorbidities associated with @entity2183 in @entity1 and @entity1 aged >=   40  years. MATERIAL AND METHODS: The EpiLUTS study was an Internet-based cross-sectional, population-representative survey involving 30,000 @entity1 and @entity1 from the USA, UK and Sweden evaluating lower urinary tract symptoms (LUTS) using the LUTS Tool. A secondary analysis of the EpiLUTS data using @entity1 with @entity2183 was performed. Descriptive statistics were used to examine the data. Logistic regressions were used to analyse associations of comorbid conditions and risk factors in @entity1 and @entity1 with @entity2183 >=   2. RESULTS: With a 59% response rate, @entity2183 >=   1 was quite common at 69% in @entity1 and 76% in @entity1 ; 28% @entity1 and 34% @entity1 had @entity2183 >=   2. Age, body mass index (in @entity1 ), Hispanic and Black responders, @entity6 , @entity101 , @entity148 and @entity308 and a history of bed-wetting were significantly associated with @entity2183 >=   2. @entity625 , @entity565 , @entity6 , @entity299 , @entity29 , @entity1494 , uterine prolapse, hysterectomy and menopausal status were all significantly associated with @entity2183 >=   2 in @entity1 . @entity1069 and @entity263 were significant in @entity1 with @entity2183 >=   2. British and Swedish @entity1 had a lesser risk of @entity2183 >=   2. CONCLUSION: @entity2183 is a highly prevalent condition associated with various risk factors and comorbidities. Treatment of @entity2183 should be aimed at these causes in a multidisciplinary fashion. Further studies are needed to look specifically at these conditions in the pathophysiology of @entity2183 .
